Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe

Core Insights - The ADOPT study highlights the effectiveness of Nanox.AI's technology in improving fracture detection and reducing healthcare costs [1][2][3] Study Findings - The ADOPT study evaluated HealthVCF across four NHS trusts and identified over 3,450 new patients with vertebral compression fractures, significantly exceeding the national average [2] - AI-enabled Fracture Liaison Services led to a reduction in patient refracture rates by up to 10% and cost savings of up to £50,000 per healthcare organization [3] Technology Development - Nanox AI's HealthOST, an FDA-cleared AI bone solution, enhances fracture measurement precision and identifies low bone mineral density in routine CT scans without additional imaging [4] Upcoming Conferences - Nanox will present findings at major medical conferences, including the British Institute of Radiology AI Congress and the WCO-IOF-ESCEO Congress, showcasing the clinical value of AI in bone health assessment [5] Company Overview - Nanox focuses on preventive healthcare through affordable medical imaging technologies, leveraging AI for improved diagnostics and patient care pathways [8][9]